Juan Andres - Apr 13, 2022 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role: Chief Technical Operations and Quality Officer
Signature: /s/ Brian Sandstrom, as Attorney-in-Fact
Stock symbol: MRNA
Transactions as of: Apr 13, 2022
Transactions value $: -$288,300
Form type: 4
Date filed: 4/15/2022, 03:09 PM
Previous filing: Apr 8, 2022
Next filing: Apr 22, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MRNA	Common Stock	Options Exercise	$28.4K	+2K	+22.05%	$14.22^*	11.1K	Apr 13, 2022	Direct	F1
transaction	MRNA	Common Stock	Sale	-$317K	-2K	-18.07%	$158.37	9.07K	Apr 13, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRNA	Stock Option (Right to Buy)	Options Exercise	$0	-2K	-23.18%	$0.00	6.63K	Apr 13, 2022	Common Stock	2K	$14.22	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 19, 2021.
F2	This option is fully vested and exercisable.

Remarks:

Chief Technical Operations and Quality Officer